צמיחת רווח נקי למניה משנה לשנה ב-12 החודשים האחרונים: Retractable Technologies, Inc. (RVP)

Driven by US reshoring policies, Retractable Technologies (RVP) is shielded from external shocks, as evidenced by the quarterly growth in net income per share, which stands at 2036.50. Revenues are based on the sale of VanishPoint systems and self-destructing syringes. High efficiency is achieved through the total robotization of assembly lines and injection molding machines, which minimize manual labor.

This indicator reflects the dynamics of quarterly earnings per share (EPS) changes, allowing for the identification of business scaling trends prior to the publication of official financial statements and preventing overpayment for the asset. By analyzing the quarterly EPS growth index, an investor can see how clinic demand for Retractable Technologies (RVP) safe syringes converts into actual financial results, confirming the efficiency of the company's operating model.